Travere Therapeutics grants inducement equity awards covering 178,580 shares to 33 new hires

Travere Therapeutics reported inducement equity awards covering 178,580 shares for 33 new employees, granted on Oct. 10, 2026. Awards included stock options for 36,000 shares, structured as non-qualified options with a 10-year term. Options vest over four years, with 25% vesting after one year, then monthly vesting over the next 36 months. Restricted stock units covered 142,580 shares, vesting over four years in 25% annual installments. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via (Ref. ID: 202610121700BIZWIRE_USPR_____20261012_BW301172) on October 12, 2026, and is solely responsible for the information contained therein. (C)